Skip to content

CYCLE-1

Heart Failure

This trial will test whether adding in tovinontrine (a medication) to standard of care medications for heart failure will reduce the chances of being hospitalized for heart failure or dying from heart disease.

null

Conditions de participation

  • Sexe:

    Any

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:
Patients with a diagnosis of heart failure, and a reduced ejection fraction ("EF") of less than 40%.
Exclusion Criteria:
Quite a few related to patient safety or medication interactions.

Lieu de l'étude

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: Pro00140660